The influence of left ventricular hypertrophyon survival in patients with coronaryartery disease: do race and gender matter?
Mark A. East, MD*,*,
James G. Jollis, MD, FACC*,
Charlotte L. Nelson, MS*,
David Marks, MD, FACC and
Eric D. Peterson, MD, MPH, FACC*
* Outcomes Research and Assessment Group, The Duke Clinical Research Institute, Durham, North Carolina, USA
Medical College of Wisconsin, Milwaukee, Wisconsin, USA
View larger version (14K):
[in a new window]
|
Figure 1 Survival curves for patients with and without left ventricular (LV) hypertrophy showing unadjusted (A) and adjusted (B) comparisons of the two groups. Numbers at the bottom of the plots show the number of patients at risk at 0 and 5 years of follow-up. H = LV mass high; N = LV mass normal.
|
|
View larger version (14K):
[in a new window]
|
Figure 2 Survival curves for patients with and without left ventricular (LV) hypertrophy showing black (A) and white (B) patients adjusted for demographic and clinical characteristics. Numbers at the bottom of the plots show the number at risk at 0 and 5 years of follow-up. H = LV mass high; N = LV mass normal.
|
|
View larger version (14K):
[in a new window]
|
Figure 3 Survival curves for patients with and without left ventricular (LV) hypertrophy showing female (A) and male (B) patients adjusted for demographic and clinical characteristics. Numbers at the bottom of the plots show the number of patients at risk at 0 and 5 years of follow-up. H = LV mass high; N = LV mass normal.
|
|
|
